Skip Navigation


European Heart Journal Advance Access originally published online on October 7, 2008
European Heart Journal 2008 29(21):2587-2591; doi:10.1093/eurheartj/ehn424
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/21/2587    most recent
ehn424v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Guerri-Guttenberg, R. A.
Right arrow Articles by Milei, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guerri-Guttenberg, R. A.
Right arrow Articles by Milei, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Chagas cardiomyopathy: Europe is not spared!{dagger}

Roberto A. Guerri-Guttenberg1, Daniel R. Grana1, Giuseppe Ambrosio2,* and José Milei1

1 Instituto de Investigaciones Cardiológicas (ININCA), University of Buenos Aires–CONICET, Buenos Aires, Argentina
2 Division of Cardiology, University of Perugia School of Medicine, Ospedale Silvestrini, S.Andrea delle Fratte, 06156 Perugia, Italy

Received 18 August 2008; accepted 28 August 2008; online publish-ahead-of-print 7 October 2008.

* Corresponding author. Tel: +39 0755271509, Fax: +39 0755271244, Email: giuseppe.ambrosio@ospedale.perugia.it

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

{dagger} Performed within a Framework Agreement between the University of Perugia, and the Instituto de Investigaciones Cardiológicas, Universidad de Buenos Aires. Back

The first 150 words of the full text of this article appear below.

Chagas’ disease was first described in 1909 by the Brazilian physician Carlos Chagas, who named the parasite Trypanosoma cruzi after his mentor, Oswaldo Cruz.1 It causes more deaths in the Americas than any other parasitic disease.1 Due to the parasite distribution throughout Central and South America, it is commonly known as the ‘American trypanosomiasis’. As such, it is considered to be an ‘exotic’ disease in Europe, where it is virtually undiagnosed. However, thanks to free circulation of individuals and employment opportunities Europe is a magnet for millions of immigrants, many of whom are from South America. We will review the compelling arguments by . . . [Full Text of this Article]


   Infection
 

   Clinical characteristics of chronic chagasic cardiomyopathy
 

   Estimation of Chagas’ disease in Europe
 

   Reported cases of Chagas’ disease in Europe
 

   Conclusions
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EuropaceHome page
J. Milei and G. Ambrosio
Chagas cardiomyopathy and implantable cardioverter defibrillator implantation: similarities and differences with dilated cardiomyopathy
Europace, February 1, 2009; 11(2): 140 - 141.
[Full Text] [PDF]